Cushing, Melissa M. http://orcid.org/0000-0001-8042-1494
Cohen, Tobias
Fitzgerald, Meghann M.
Rand, Sophie
Sinfort, Abraham
Chen, Dennis
Keltner, Nadia
Ong, Sidney
Parra, Priscilla
Benabdessadek, Denden
Jimenez, Alexandra
Haas, Thorsten
Lau, Christopher
Girardi, Natalia Ivascu
DeSimone, Robert A.
Article History
Received: 19 April 2024
Accepted: 12 August 2024
First Online: 27 September 2024
Declarations
:
: This study protocol has been reviewed and approved by the IRB of Weill Cornell Medicine through a collaboration with the BRANY IRB (Lake Success, NY). The need for consent was waived by the IRB.
: Not applicable.
: MMC is a consultant for Cerus Corporation, Octapharma, Haemonetics, and CSL Behring. NK is a full-time employee of Cerus Corporation and owns stock in the company. TH is a consultant for Cerus Corporation, Octapharma, Grifols, and CSL Behring. Remaining authors declare no competing interests.